Catalyst
Slingshot members are tracking this event:
Cellectar Biosciences (CLRB) Granted Orphan Drug Designation for CLR 131 to Treat Neuroblastoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLRB |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 19, 2018
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Neuroblastoma, Clr 131, Orphan Drug Designation
